Biocompatible Polymer Coated Paramagnetic Nanoparticles for Doxorubicin Delivery: Synthesis and Anticancer Effects Against Human Breast Cancer Cells
Source abstract
Abstract
To increase the efficacy of doxorubicin in induction of apoptosis, pH-responsive nanocarriers with an average particle size of 20 nm by using chitosan-polymethacrylic acid (CTS-PMAA) shells and Fe3O4 cores via in situ polymerization approach were synthesized. Doxorubicin hydrochloride (DOX) was loaded effectively to nanocarrier through electrostatic interactions and strong hydrogen banding. The cumulative release of DOX-loaded nanoparticles was pH dependent with a maximum release rate at pH 5.8. In vitro cytotoxicity assay revealed the biocompatibility of blank nanocarrier and superior anticancer performance of DOX-loaded nanoparticles verified by DAPI staining and MTT assay tests.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. 10.1111/cbdd.1214510.1111/cbdd.12145 ↗
2. 10.1038/nrc156610.1038/nrc1566 ↗
3. 10.3109/1061186X.2013.87664510.3109/1061186X.2013.876645 ↗
4. Marchal F. · Bull. Cancer · 2008 · 95 · 1149
5. 10.2478/v1007-010-0037-410.2478/v1007-010-0037-4 ↗
6. 10.7314/APJCP.2014.15.13.531110.7314/APJCP.2014.15.13.5311 ↗
7. 10.1016/S0168-3659(02)00212-210.1016/S0168-3659(02)00212-2 ↗
8. 10.1016/S0378-5173(98)00365-210.1016/S0378-5173(98)00365-2 ↗
9. 10.1016/j.biomaterials.2007.08.05010.1016/j.biomaterials.2007.08.050 ↗
10. 10.1007/s10549-008-9948-x10.1007/s10549-008-9948-x ↗
11. 10.1016/j.phrs.2013.01.00910.1016/j.phrs.2013.01.009 ↗
12. 10.1021/bc010052t10.1021/bc010052t ↗
13. Sahoo Y. · Biomater · 2001 · 17 · 7907
14. 10.1016/S0142-9612(01)00267-810.1016/S0142-9612(01)00267-8 ↗
15. 10.1039/c3nr01384g10.1039/c3nr01384g ↗
16. 10.1016/j.biomaterials.2010.01.05710.1016/j.biomaterials.2010.01.057 ↗
17. 10.1021/am101196v10.1021/am101196v ↗
18. 10.2217/17435889.1.1.3110.2217/17435889.1.1.31 ↗
19. 10.1021/la010703+10.1021/la010703+ ↗
20. 10.1021/ja047414310.1021/ja0474143 ↗
21. 10.1016/j.ijbiomac.2008.09.00710.1016/j.ijbiomac.2008.09.007 ↗
22. 10.1016/j.biomaterials.2010.07.06110.1016/j.biomaterials.2010.07.061 ↗
23. Manaspon C. · J. Nanomater · 2012
24. 10.1016/j.ijbiomac.2010.12.01410.1016/j.ijbiomac.2010.12.014 ↗
25. 10.1016/j.biochi.2010.08.00210.1016/j.biochi.2010.08.002 ↗
26. 10.3109/10717544.2013.83871410.3109/10717544.2013.838714 ↗
27. 10.1080/15685551.2013.77130310.1080/15685551.2013.771303 ↗
28. 10.1089/dna.2012.194610.1089/dna.2012.1946 ↗
29. 10.1016/S0014-3057(02)00174-X10.1016/S0014-3057(02)00174-X ↗
30. 10.1016/j.biomaterials.2009.04.02110.1016/j.biomaterials.2009.04.021 ↗
31. 10.1021/jp201053d10.1021/jp201053d ↗
32. 10.1080/00914037.2013.85423410.1080/00914037.2013.854234 ↗
33. Liu Q. · Int. J. Nanomed · 2012 · 7 · 999
34. 10.1016/j.ijpharm.2011.10.01310.1016/j.ijpharm.2011.10.013 ↗
35. 10.1016/j.ejpb.2012.11.01910.1016/j.ejpb.2012.11.019 ↗
36. 10.1002/chem.20100296010.1002/chem.201002960 ↗
37. 10.1039/c0jm00506a10.1039/c0jm00506a ↗
38. 10.1016/j.biomaterials.2007.08.05010.1016/j.biomaterials.2007.08.050 ↗
39. 10.1211/jpp.59.4.000110.1211/jpp.59.4.0001 ↗